Lunardi-Maia Tânia, Schuelter-Trevisol Fabiana, Galato Dayani
Núcleo de Pesquisa em Atenção Farmacêutica e Estudos de Utilização de Medicamentos, Universidade do Sul de Santa Catarina - UNISUL, Tubarão, SC, Brasil.
Centro de Pesquisas Clínicas do Hospital Nossa Senhora da Conceição, Universidade do Sul de Santa Catarina - UNISUL, Tubarão, SC, Brasil.
Rev Bras Ginecol Obstet. 2014 Dec;36(12):541-7. doi: 10.1590/so100-720320140005051.
To identify the profile of use of medication during the first trimester of pregnancy with emphasis on safety assessment and on the adoption of folic acid and ferrous sulfate by pregnant women attended at a Basic Health Unit in Brazil.
This was a cross-sectional study nested in a cohort of pregnant women. Medications were classified according to the Anatomical Therapeutic Chemical (ATC), and their safety was evaluated according to the Food and Drug Administration (FDA) and the Brazilian Health Surveillance Agency (ANVISA). The adoption of ferrous sulfate and folic acid was investigated according to the protocol set forth by the Brazilian Ministry of Health.
The survey included 212 pregnant women, 46.7% of whom were taking medications at the time of pregnancy diagnosis, and 97.6% used medication during the first trimester after diagnosis. The highest percentage of self-medication occurred before the beginning of prenatal care (64.9%). According to the FDA criteria, there was a high level of exposure to D and X risk drugs before the beginning of prenatal care (23.0%), which was also observed for drugs not recommended by ANVISA (36.5%). Of the surveyed sample, 32.5% did not follow the protocol of the Brazilian Ministry of Health. In all, 67.9% of pregnant women had inadequate drug exposure. There was a difference between the proportions of drugs used according to the ATC, and the main anatomical groups identified were the drugs that act on blood and blood-forming organs, and anti-infective medications for systemic use. When pregnancy was diagnosed, the use of a large number of medications that act on the genitourinary system and sex hormones (16.2%) was identified, such as oral contraceptives, a fact probably related to the percentage of unplanned pregnancies (67.0%), on the same occasion 4 pregnant women used folic acid and 3 used ferrous sulphate.
The present results show that a large number of medications are used during pregnancy. Even if there was little exposure to drugs at the time of diagnosis, there is an overuse of potentially risky medications and self-medication during the first trimester of pregnancy.
确定巴西一家基层卫生单位就诊的孕妇在妊娠早期的用药情况,重点是安全性评估以及孕妇对叶酸和硫酸亚铁的服用情况。
这是一项嵌套在孕妇队列中的横断面研究。药物根据解剖治疗学化学分类系统(ATC)进行分类,并根据美国食品药品监督管理局(FDA)和巴西卫生监督局(ANVISA)评估其安全性。根据巴西卫生部制定的方案调查硫酸亚铁和叶酸的服用情况。
该调查纳入了212名孕妇,其中46.7%在妊娠诊断时正在服药,97.6%在诊断后的妊娠早期使用了药物。自我用药比例最高的情况发生在产前护理开始之前(64.9%)。根据FDA标准,在产前护理开始之前,有较高比例的孕妇接触D类和X类风险药物(23.0%),对于ANVISA不推荐使用的药物也观察到了类似情况(36.5%)。在被调查的样本中,32.5%未遵循巴西卫生部的方案。总体而言,67.9%的孕妇药物暴露情况不佳。根据ATC分类,所使用药物的比例存在差异,确定的主要解剖学组是作用于血液和造血器官的药物以及全身用抗感染药物。在诊断妊娠时,发现有大量作用于生殖泌尿系统和性激素的药物被使用(16.2%),如口服避孕药,这一事实可能与意外怀孕的比例(67.0%)有关,在同一时期,有4名孕妇使用了叶酸,3名孕妇使用了硫酸亚铁。
目前的结果表明,孕期使用了大量药物。即使在诊断时接触药物较少,但在妊娠早期仍存在潜在风险药物的过度使用和自我用药情况。